Adlai Nortye Ltd ADR (ANL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANL | IRD | XFOR | ||
| Company | Adlai Nortye Ltd ADR | Opus Genetics Inc | X4 Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.24 | 4.77 | 3.65 | ||
| High | 9.80 | 5.10 | 3.86 | ||
| Low | 8.65 | 4.68 | 3.65 | ||
| Latest | 8.91 | 4.89 | 3.76 | ||
| Change | -0.33 | +0.12 | +0.06 | ||
| % Change | -3.57% | +2.52% | +1.62% | ||
| Volume | 175,100 | 1,518,400 | 282,100 | ||
| 20-Day Average Volume | 241,735 | 1,181,765 | 552,850 | ||
| Previous Close | 9.24 | 4.77 | 3.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 9.36 | 3.80 | 3.39 | ||
| 20-Day Raw Stochastic | 47.75% | 91.46% | 90.29% | ||
| 20-Day Relative Strength | 60.28 | 74.73 | 54.89 | ||
| Weighted Alpha | +22.06 | +394.03 | -60.10 | ||
| Today's Opinion | 88% Buy | 100% Buy | 64% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 48% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.36% since 02/27/26 | +17.55% since 02/27/26 | +9.30% since 02/27/26 | ||
| Low | 7.31 on 03/04/26 | 3.83 on 03/02/26 | 3.23 on 03/02/26 | ||
| High | 9.80 on 03/06/26 | 5.10 on 03/06/26 | 3.86 on 03/06/26 | ||
| 1-Month | |||||
| %Chg | -10.99% since 02/06/26 | +62.46% since 02/06/26 | +5.62% since 02/06/26 | ||
| Low | 7.21 on 02/27/26 | 3.01 on 02/09/26 | 2.83 on 02/18/26 | ||
| High | 10.77 on 02/09/26 | 5.10 on 03/06/26 | 3.86 on 03/06/26 | ||
| 3-Month | |||||
| %Chg | +782.18% since 12/05/25 | +115.42% since 12/05/25 | -5.53% since 12/05/25 | ||
| Low | 0.88 on 12/09/25 | 1.88 on 01/12/26 | 2.83 on 02/18/26 | ||
| High | 12.09 on 02/03/26 | 5.10 on 03/06/26 | 4.55 on 12/24/25 | ||
| 6-Month | |||||
| %Chg | +409.14% since 09/05/25 | +285.04% since 09/05/25 | +7.43% since 09/05/25 | ||
| Low | 0.88 on 12/09/25 | 1.28 on 09/08/25 | 2.80 on 10/15/25 | ||
| High | 12.09 on 02/03/26 | 5.10 on 03/06/26 | 4.55 on 12/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 328,779 | 337,234 | 328,763 | ||
| Shares Outstanding, K | 36,900 | 68,964 | 87,437 | ||
| Annual Sales | 0 | 10,990,000 | 2,560,000 | ||
| Annual Net Income | -51,870,000 | -57,530,000 | -37,450,000 | ||
| Last Quarter Sales | 0 | 3,080,000 | 1,770,000 | ||
| Last Quarter Net Income | -63,397,000 | -17,450,000 | -29,820,000 | ||
| 60-Month Beta | -1.50 | 0.45 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/29/23 | -0.12 on 11/12/25 | -0.69 on 11/05/25 | ||
| Latest Earnings Date | 04/29/26 | 03/30/26 | 03/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||